https://www.pharmaceutical-technology.com/analyst-comment/jak-inhibitors-sales-increase-covid/
While JAK inhibitors have seen success during the pandemic, they were not as frequently prescribed as subcutaneous (SC) biologics.
jak inhibitorssee salesprescriptiongrowthdespite